← Open Payments lookup

DANIEL RAPPAPORT: Open Payments

NPI 1003868381 · WHITEHALL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$479 in 29 payments from 16 companies in 2025. Trend: 2023 $664 · 2024 $493 · 2025 $479

Food & beverage: $479
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP4$69
Esperion Therapeutics, Inc.3$48
Amgen Inc.3$47
Boehringer Ingelheim Pharmaceuticals, Inc.2$36
ABBVIE INC.2$33
Otsuka America Pharmaceutical, Inc.2$33
Salix Pharmaceuticals, a division of Bausch Health US, LLC2$30
Madrigal Pharmaceuticals2$30
Lilly USA, LLC2$30
Astellas Pharma US Inc1$22

Products named: NEXLETOL, JARDIANCE, VRAYLAR, REXULTI, OTEZLA, XIFAXAN, REZDIFFRA, ZEPBOUND.

Industry payments across PA — which companies pay providers there.